A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

MP Busch, SA Glynn, SL Stramer, DM Strong… - …, 2005 - Wiley Online Library
BACKGROUND: Estimates for human immunodeficiency virus (HIV)‐1 and hepatitis C virus
(HCV) transfusion‐transmitted risks have relied on incidence derived from repeat donor …

Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

SF O'Brien, QL Yi, W Fan, V Scalia, SH Kleinman… - …, 2007 - Wiley Online Library
BACKGROUND: New testing methods such as nucleic acid amplification testing (NAT) and
chemiluminescent serologic assays have been introduced, more precise estimates for …

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of …

S Zou, KA Dorsey, EP Notari, GA Foster… - …, 2010 - Wiley Online Library
BACKGROUND: Nucleic acid testing (NAT) for human immunodeficiency virus (HIV) and
hepatitis C virus (HCV) was introduced for blood donation screening in the United States in …

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT

JJAM Weusten, HAJ Van Drimmelen, PN Lelie - Transfusion, 2002 - Wiley Online Library
BACKGROUND: Blood transfusion centers around the world have introduced minipool NAT
to reduce the risk of HBV, HCV, and HIV transmission by blood donations drawn in the …

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000

JA Chiavetta, M Escobar, AM Newman, Y He… - Cmaj, 2003 - Can Med Assoc
Background: Since 1990, the Canadian Red Cross Society and Canadian Blood Services
have been testing blood donors for hepatitis C virus (HCV) antibody and HCV nucleic acids …

[引用][C] The risk of transfusion-transmitted viral infections

G Brammer, NC Kunkel, MD Baker - N Engl J Med, 1996 - annemergmed.com
The authors of this article state that accurate risk estimates of transfusion-transmitted
infectious disease are most directly obtained by studying the rate of infection prospectively in …

[HTML][HTML] Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)

J Pillonel, S Laperche - Eurosurveillance, 2005 - eurosurveillance.org
Monitoring trends in residual risk of transfusion-transmitted viral infections is important to
assess improvements in blood safety and to adapt the risk reduction policies. These trends …

Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe

WK Roth, M Weber, S Buhr, C Drosten… - …, 2002 - Wiley Online Library
BACKGROUND: HCV and HIV‐1 NAT of all blood donations was initiated at our institutions
in January 1997 to reduce the residual risk of transfusion‐transmitted virus infections. The …

Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population

RY Dodd, EP Notari IV, SL Stramer - Transfusion, 2002 - Wiley Online Library
BACKGROUND: There has been continuing prog‐ress in measures to reduce the risk of
transfusion‐transmitted infection, including introduction of serologic tests of increased …

[PDF][PDF] Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.

SH Kleinman, N Lelie, MP Busch - Transfusion, 2009 - researchgate.net
As the safety of blood transfusion has dramati-cally improved with respect to transmission of
viral infection, one of the remaining challenges has been to accurately estimate the risk …